Award
NIH Reporter #3U01NS110772-05S1
FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial
Recipient
National Institute of Neurological Disorders and Stroke
Award Amount
$389,840.00
Ceiling
$389,840.00
Awarded
February 27, 2026
Identifier
3U01NS110772-05S1
NIH grant awarded to test the efficacy of Recombinant Factor VIIa for acute hemorrhagic stroke treatment within 2 hours of onset, involving multiple international sites.
Description
The project aims to test the efficacy of Recombinant Factor VIIa within 2 hours of stroke onset. The project involves multiple international sites and aims to establish a scientifically proven treatment for acute ICH. The project duration is from March 1, 2020, to December 31, 2026.